160 related articles for article (PubMed ID: 9134822)
1. Clinical and electrophysiological correlation in chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin therapy: a case report.
Han NH; Huang CC; Tsai CP
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jan; 59(1):42-6. PubMed ID: 9134822
[TBL] [Abstract][Full Text] [Related]
2. [High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy].
Tomiyama M; Baba M; Matsunaga M; Takada H; Okushima T; Narita S; Takebe K
No To Shinkei; 1992 Nov; 44(11):979-82. PubMed ID: 1296721
[TBL] [Abstract][Full Text] [Related]
3. [The clinical usefulness of high-dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy].
Kubori T; Mezaki T; Kaji R; Kimura J; Hamaguchi K; Hirayama K; Kanazawa I; Miyatake T; Mannen T; Kowa H; Yanagisawa N; Goto I; Osame M; Kanda M; Tashiro K; Baba M; Kuroiwa Y; Nagatomo H; Mitsuma T; Shigeta Y; Saida T; Nakajima K; Kawamura J; Murai Y; Kiuchi T
No To Shinkei; 1999 Feb; 51(2):127-35. PubMed ID: 10198901
[TBL] [Abstract][Full Text] [Related]
4. Late motor involvement in cases presenting as "chronic sensory demyelinating polyneuropathy".
Berger AR; Herskovitz S; Kaplan J
Muscle Nerve; 1995 Apr; 18(4):440-4. PubMed ID: 7715630
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.
Hahn AF; Bolton CF; Zochodne D; Feasby TE
Brain; 1996 Aug; 119 ( Pt 4)():1067-77. PubMed ID: 8813271
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin.
Hahn AF
Neurology; 1998 Dec; 51(6 Suppl 5):S16-21. PubMed ID: 9851725
[TBL] [Abstract][Full Text] [Related]
7. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
8. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome.
Viala K; Renié L; Maisonobe T; Béhin A; Neil J; Léger JM; Bouche P
Brain; 2004 Sep; 127(Pt 9):2010-7. PubMed ID: 15289267
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin in chronic relapsing polyneuropathy.
Tuohy PG
N Z Med J; 1992 Feb; 105(928):60-1. PubMed ID: 1311826
[No Abstract] [Full Text] [Related]
10. [Rapid improvement of nerve conduction in a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
Saito Y; Yokota T
Rinsho Shinkeigaku; 1993 Oct; 33(10):1066-9. PubMed ID: 8293607
[TBL] [Abstract][Full Text] [Related]
11. Chronic steadily progressive central and peripheral predominantly motor demyelination, involving the cranial nerves, responsive to immunoglobulins.
Bentes C; de Carvalho M; de Sá J; Luís ML
Electromyogr Clin Neurophysiol; 1999; 39(1):33-7. PubMed ID: 10076759
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
13. [A quadriplegic patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who responded well to corticosteroids and intravenous immunoglobulin therapy].
Fukae J; Okuma Y; Noda K; Fujishima K; Goto K; Mizuno Y
No To Shinkei; 2001 Dec; 53(12):1115-8. PubMed ID: 11806118
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
[TBL] [Abstract][Full Text] [Related]
15. Unexpected recovery in a newborn with severe hypomyelinating neuropathy.
Levy BK; Fenton GA; Loaiza S; Hayat GR
Pediatr Neurol; 1997 Apr; 16(3):245-8. PubMed ID: 9165518
[TBL] [Abstract][Full Text] [Related]
16. Chronic inflammatory demyelinating polyneuropathy in a patient with hyperIgEaemia.
Kimura A; Yoshino H; Yuasa T
J Neurol Sci; 2005 Apr; 231(1-2):89-93. PubMed ID: 15792827
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory demyelinating polyneuropathy. Conduction failure before and during immunoglobulin or plasma therapy.
van der Meché FG; Vermeulen M; Busch HF
Brain; 1989 Dec; 112 ( Pt 6)():1563-71. PubMed ID: 2597997
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin therapy in the inflammatory neuropathies.
Churchyard A; Day T; Grainger K; Mastaglia FL
Clin Exp Neurol; 1991; 28():168-79. PubMed ID: 1821824
[TBL] [Abstract][Full Text] [Related]
19. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.
Gorson KC; Allam G; Ropper AH
Neurology; 1997 Feb; 48(2):321-8. PubMed ID: 9040714
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of electrophysiological findings between CIDP and HMSN-1].
Hasegawa O; Matsumoto S; Iino M; Kurita R; Kubota Y
No To Shinkei; 1999 May; 51(5):411-4. PubMed ID: 10396746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
